University of Notre Dame Du Lac

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), University of Notre Dame Du Lac reported 1 stock position worth $74.8 million. Its top holding was Berkshire Hathaway Class B (BRK.B) at 100.0% of the portfolio. Compared with Q4 2023, it sold out of 1 and reduced 1. The biggest sale was an exit from Spyre Therapeutics (SYRE).

Most Recent 13F
Q3 2024
Location
SOUTH BEND, IN
CIK
0000903514
Portfolio Value
$74.8M (Q1 2024)
SEC Filing
0000903514-24-000006 ↗ filed May 14, 2024

Holdings Value

0$20.0M$40.0M$60.0M$80.0M Q1 2024: $74.8M $74.8M Q1 2024 Q2 2024: $72.3M Q2 2024 Q3 2024: $66.8M Q3 2024

Holdings 1 stocks · $74.8M

BRK.B Berkshire Hathaway Inc. Class B 100.00% 177,781 $74.8M Reduce -25.6%

Portfolio Sells Q4 2023 → Q1 2024

SYRE Spyre Therapeutics Inc. Sold out 0.00% −12.73
BRK.B Berkshire Hathaway Inc. Class B Reduce -25.6% 100.00% +12.73

Portfolio Buys Q4 2023 → Q1 2024

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2024 1$66.8MBRK.B
Q2 2024 1$72.3MBRK.B
Q1 2024 1$74.8MBRK.B